Cheng, Tuck Seng
Noor, Urwah
Watts, Eleanor
Pollak, Michael
Wang, Ye
McKay, James
Atkins, Joshua
Masala, Giovanna
Sánchez, Maria-Jose
Agudo, Antonio
Castilla, Jesús
Aune, Dagfinn
Colorado-Yohar, Sandra M.
Manfredi, Luca
Gunter, Marc J.
Pala, Valeria
Josefsson, Andreas
Key, Timothy J.
Smith-Byrne, Karl
Travis, Ruth C.
Article History
Received: 5 May 2023
Accepted: 20 September 2023
First Online: 3 June 2024
Declarations
:
: The authors declare no competing interests.
: BMI body mass index.CI confidence interval.ELISA enzyme-linked immunosorbent assay.EPIC European Prospective Investigation into Cancer and Nutrition.IGFBP IGF binding protein.IGF-I insulin-like growth factor-I.IRMA immunoradiometric assay.IQR interquartile range.LOD limit of detection.MR Mendelian randomization.PSA prostate-specific antigen.SHBG sex hormone binding globulin.TNM tumor-node-metastasis.
: All participants provided written informed consent to participate in the EPIC study. The EPIC study was approved by the Ethics Committee of the International Agency for Research on Cancer (IARC) and all EPIC centers. All methods were carried out in accordance with relevant guidelines and regulations.
: NA.